These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
213 related items for PubMed ID: 3803566
1. New N-amino acid derivatives of daunorubicin. Dzieduszycka M, Stefanska B, Borowski E, Martelli S. Farmaco Sci; 1986 Nov; 41(11):881-91. PubMed ID: 3803566 [Abstract] [Full Text] [Related]
2. Antitumor activity of new N-substituted daunorubicin derivatives. Mazerska Z, Woynarowska B, Stefanska B, Borowski E, Martelli S. Drugs Exp Clin Res; 1987 Nov; 13(6):345-51. PubMed ID: 3308387 [Abstract] [Full Text] [Related]
3. Synthesis and antileukemic activity of N-enamine derivatives of daunorubicin, 5-iminodaunorubicin, and doxorubicin. Stefańska B, Dzieduszycka M, Bontemps-Gracz M, Borowski E, Martelli S. J Antibiot (Tokyo); 1988 Feb; 41(2):193-8. PubMed ID: 3356607 [Abstract] [Full Text] [Related]
4. Enhanced antitumor properties of 3'-(4-morpholinyl) and 3'-(4-methoxy-1-piperidinyl) derivatives of 3'-deaminodaunorubicin. Mosher CW, Wu HY, Fujiwara AN, Acton EM. J Med Chem; 1982 Jan; 25(1):18-24. PubMed ID: 7086816 [Abstract] [Full Text] [Related]
5. [Synthesis and properties of the 14-amino derivatives of daunorubicin and carminomycin]. Povarov LS, Isaeva NN. Antibiotiki; 1979 Feb; 24(2):92-6. PubMed ID: 434804 [Abstract] [Full Text] [Related]
6. Synthesis and biological activity of the two isomeric 2'-C-methyl daunomycins. Rocherolle V, Olesker A, Lukacs G. J Antibiot (Tokyo); 1989 Sep; 42(9):1393-7. PubMed ID: 2793594 [Abstract] [Full Text] [Related]
19. Synthesis and antitumor activity of 4-demethoxydaunorubicin, 4-demethoxy-7,9-diepidaunorubicin, and their beta anomers. Arcamone F, Bernardi L, Giardino P, Patelli B, Marco A, Casazza AM, Pratesi G, Reggiani P. Cancer Treat Rep; 1976 Jul; 60(7):829-34. PubMed ID: 1009518 [Abstract] [Full Text] [Related]
20. 4-Demethoxy-3'-deamino-3'-aziridinyl-4'-methylsulphonyl-daunorubicin (PNU-159548), a novel anticancer agent active against tumor cell lines with different resistance mechanisms. Marchini S, Damia G, Broggini M, Pennella G, Ripamonti M, Marsiglio A, Geroni C. Cancer Res; 2001 Mar 01; 61(5):1991-5. PubMed ID: 11280757 [Abstract] [Full Text] [Related] Page: [Next] [New Search]